PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING QUISQUALATE RECEPTOR ANTAGONIST QUINOXALINEDIONE AND SUITABLE FOR TREATING PARKINSON'S DISEASE
摘要
The new use of antagonists of the AMPA receptor complex and its physiologically compatible salts as pharmaceutical agents for prevention and treatment of Parkinson's disease as well as pharmaceutical agents, which contain these compounds, is described.